0000315545-14-000003.txt : 20141015 0000315545-14-000003.hdr.sgml : 20141015 20141014173946 ACCESSION NUMBER: 0000315545-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141015 DATE AS OF CHANGE: 20141014 EFFECTIVENESS DATE: 20141015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROVECTUS BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000315545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900031917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-226419 FILM NUMBER: 141155977 BUSINESS ADDRESS: STREET 1: 7327 OAK RIDGE HWY STREET 2: SUITE B CITY: KNOXVILLE STATE: TN ZIP: 37931 BUSINESS PHONE: 865-769-4011 MAIL ADDRESS: STREET 1: 7327 OAK RIDGE HWY STREET 2: SUITE B CITY: KNOXVILLE STATE: TN ZIP: 37931 FORMER COMPANY: FORMER CONFORMED NAME: PROVECTUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020417 FORMER COMPANY: FORMER CONFORMED NAME: ZAMAGE DIGITAL IMAGING INC DATE OF NAME CHANGE: 20011126 FORMER COMPANY: FORMER CONFORMED NAME: SPM GROUP INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0707 D LIVE 0000315545 PROVECTUS BIOPHARMACEUTICALS, INC. 7327 OAK RIDGE HWY SUITE A KNOXVILLE TN TENNESSEE 37931 865-769-4011 DELAWARE PROVECTUS PHARMACEUTICALS INC ZAMAGE DIGITAL IMAGING INC SPM GROUP INC Corporation true Peter R. Culpepper 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Executive Officer CFO, COO, CAO Alfred E. Smith IV 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Director Kelly M. McMasters 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Director H. Craig Dees 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Executive Officer Director CEO Jan Koe 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Director Eric A. Wachter 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Executive Officer Chief Technology Officer Tim Scott 7327 Oak Ridge Highway Suite A Knoxville TN TENNESSEE 37931 Executive Officer President Pharmaceuticals Decline to Disclose 06b false true false true true false 0 Network 1 Financial Securities, Inc. 13577 None None The Galleria, Penthouse 2 Bridge Avenue, Building 2 Red Bank NJ NEW JERSEY 07701 IL ILLINOIS NY NEW YORK VA VIRGINIA CT CONNECTICUT OH OHIO TX TEXAS FL FLORIDA true 15000000 0 15000000 Sales in the offering will be staged incrementally at the sole discretion of the Company. false 0 0 0 Placement agent will receive: (i) 10% commission of the aggregate purchase price of the securities sold; (ii) 3% of the offering proceeds as non-accountable expenses; and (iii) cashless warrants equal to 10% of total units sold with $1.25 exercise price. 0 false PROVECTUS BIOPHARMACEUTICALS, INC. /s/ Peter R. Culpepper Peter R. Culpepper CFO, COO & CAO 2014-10-14